Tag: ESC 2018
ESC 2018: TMVI associated with “excellent outcomes” for valve-in-valve procedures
New results from the ...
ESC 2018: First US FDA-approved study shows TAVI is safe for low-risk patients
The LRT (Low Risk TAV...
ESC 2018: Novel imaging biomarker can predict risk of cardiac mortality
Milind Desai (Cleveland C...
ESC 2018: All-cause mortality in cardiogenic shock multivessel PCI only increased during first 30 days
One-year data from the CU...
ESC 2018: Ticagrelor monotherapy approach does not challenge current DAPT approach
The GLOBAL LEADERS tr...
ESC 2018: Higher all-cause mortality with Orsiro at five years than with Xience
According to the five...
